MCCC2

MCCC2 encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), heterodimerizing with the biotin-containing MCCC1 alpha-subunit to drive leucine catabolism, and patient mutations that map to conserved residues cause near-total loss of MCC enzymatic activity, establishing MCCC2 as essential for the holoenzyme's function (PMID:11406611, PMID:14680978). The MCCC1/MCCC2 complex and its carboxylase activity are post-translationally tuned: SIRT4 directly deacetylates MCCC2 at K269, stabilizing the heterodimer and enhancing carboxylase activity to increase acetyl-CoA output (PMID:40384857), while MCCC2 protein abundance is limited by NEDD4-mediated ubiquitination and proteasomal degradation, an event promoted by ECHDC2 binding (PMID:38783226). Through this leucine-to-acetyl-CoA metabolic axis, MCCC2 supports glycolysis and feeds nutrient-sensing signaling, acting upstream of leucine-dependent mTOR activation and of ERK and P38 MAPK signaling, and the SIRT4-driven acetyl-CoA increase fuels H3K27 acetylation and stem cell-like transcriptional reprogramming in tumor cells (PMID:33407468, PMID:38783226, PMID:40384857, PMID:41836158). Beyond metabolism, MCCC2 has non-canonical roles: it complexes with the telomere-binding protein TRF2 and is required to maintain telomere length independently of telomerase, while also shaping mitochondrial fusion (PMID:37828426), and it directly binds LTBP1 to competitively block SMURF1-mediated ubiquitination of LTBP1, thereby stabilizing LTBP1 and activating TGF-β signaling (PMID:42251191).

1. 2001 High

   Established the molecular identity and essential function of MCCC2 by showing it encodes the non-biotin beta-subunit of MCC and that its loss abolishes leucine-catabolic carboxylase activity.

   Evidence cDNA cloning, patient mutation identification, and MCC enzyme activity assay in patient fibroblasts

   PMID:11406611

   Open questions at the time

   • Did not resolve the structural basis of MCCC1/MCCC2 heterodimerization
   • No mechanism for how individual residues contribute to catalysis
2. 2003 High

   Confirmed the pathogenic mechanism of specific MCCB missense alleles by demonstrating that conserved-residue mutations directly cripple MCC activity upon reconstitution.

   Evidence Transient transfection of mutant constructs into MCC-deficient fibroblasts followed by enzyme activity assay

   PMID:14680978

   Open questions at the time

   • Did not map mutations onto a structural model
   • No distinction between effects on folding, stability, or catalytic chemistry
3. 2021 Medium

   Placed MCCC2 within cancer metabolism by linking its leucine-catabolic activity to acetyl-CoA production, glycolysis, and ERK signaling in HCC cells.

   Evidence siRNA/sgRNA knockdown, metabolite measurement, ERK activation assay, and xenograft in HCC cells

   PMID:33407468

   Open questions at the time

   • Pathway placement inferred rather than mechanistically dissected
   • No direct demonstration that acetyl-CoA mediates the ERK and glycolytic effects
4. 2023 Medium

   Revealed a non-metabolic role by showing MCCC2 complexes with TRF2 and is required to maintain telomere length independently of telomerase, while influencing mitochondrial fusion.

   Evidence Co-immunoprecipitation, knockdown/knockout, telomere length and TERT activity assays, fusion-marker Western blot, and electron microscopy

   PMID:37828426

   Open questions at the time

   • Mechanism connecting a mitochondrial enzyme to nuclear telomeres unresolved
   • Single Co-IP without structural characterization of the MCCC2-TRF2 interaction
   • Causal link between mitochondrial fusion changes and telomere effects not established
5. 2024 Medium

   Defined how MCCC2 protein levels are controlled, identifying ECHDC2-promoted, NEDD4-mediated ubiquitination as the route to MCCC2 turnover with downstream effects on P38 MAPK and aerobic glycolysis.

   Evidence Reciprocal co-immunoprecipitation, Western blotting, glycolysis assays, and xenograft in gastric cancer cells

   PMID:38783226

   Open questions at the time

   • Ubiquitination site(s) on MCCC2 not mapped
   • Direct E3-substrate transfer not reconstituted in vitro
6. 2025 High

   Identified a post-translational activating mechanism: SIRT4 deacetylation of MCCC2 K269 stabilizes the MCCC1/MCCC2 complex, boosts carboxylase activity, and raises acetyl-CoA to drive H3K27 acetylation and stemness reprogramming.

   Evidence Deacetylation assay, K269 site-directed mutagenesis, complex Co-IP, enzyme activity and acetyl-CoA measurement, H3K27ac analysis, and in vivo tumor assay

   PMID:40384857

   Open questions at the time

   • How K269 acetylation alters heterodimer affinity at the structural level unknown
   • Upstream signals controlling SIRT4 engagement of MCCC2 not defined
7. 2026 High

   Established a moonlighting role in signaling, showing MCCC2 directly binds LTBP1 and competitively blocks SMURF1-mediated LTBP1 ubiquitination to activate TGF-β signaling and drive bone metastasis.

   Evidence LC-MS/MS, co-immunoprecipitation, GST pulldown, ubiquitination assay, and in vivo bone metastasis model in prostate cancer

   PMID:42251191

   Open questions at the time

   • Whether this function requires catalytically active MCC is unclear
   • Subcellular site of the MCCC2-LTBP1 interaction not localized
8. 2026 Medium

   Positioned MCCC2 upstream of leucine-dependent mTOR signaling, with rapamycin and leucine deprivation reversing the consequences of MCCC2 knockdown in TNBC cells.

   Evidence siRNA knockdown with rapamycin rescue and leucine-free culture, plus proliferation/migration/invasion assays

   PMID:41836158

   Open questions at the time

   • Limited mechanistic detail linking MCCC2 metabolism to mTOR activation
   • Whether the effect is mediated by leucine flux versus a downstream metabolite untested

• It remains unresolved how MCCC2's canonical mitochondrial carboxylase activity is mechanistically coupled to its non-catalytic roles in telomere maintenance, TGF-β signaling, and nutrient-sensing pathways.
• No structural model of MCCC2 in any of its complexes
• No test of whether moonlighting functions depend on carboxylase activity or mitochondrial localization
• Physiological versus cancer-specific relevance of the non-canonical roles not delineated